Navigation Links
Statement by US Oncology on FDA Label on Erythropoiesis Stimulating Agents (ESAs)
Date:11/8/2007

HOUSTON, Nov. 8 /PRNewswire-USNewswire/ -- US Oncology, who supports one of the nation's largest cancer treatment and research networks representing over 1,100 oncologists nationwide, supports the FDA's label outlining the safe and effective administration of ESAs at the minimum level of the range 10-12 grams per deciliter (gm/dL), a declaration that has long been a central part of the US Oncology physician network's recommended clinical guidelines.

Recently, a number of health concerns have arisen for ESA dosing levels exceeding 12 gm/dL. The FDA's new label repeatedly notes the upper safety limit is 12 gm/dL, and preserves physician discretion to use the lowest dose possible in order to avoid blood transfusions - widely regarded as cumbersome for patients and carry several health risks -- and to continue treatment within the range of 10-12 gm/dL.

Physician discretion remains the critical point of debate. The current FDA labeling provides flexibility for patients and physicians to decide whether the use of ESAs is appropriate for each individual case. These considerations may include the type and anticipated duration of chemotherapy and its known impact on blood cell reproduction.

The new FDA label supports anemia management protocols adopted by US Oncology, the American Society of Hematology (ASH), the American Society of Clinical Oncology (ASCO), the European Agency for the Evaluation of Medicinal Products (EMEA), and all major U.S. health insurance plans. All of these groups support the same physician-centric approach and reflect a target range of 10 gm/dL and 12 gm/dL. This treatment range stands in contrast only to the National Coverage Determination (NCD) recently adopted by the Centers for Medicare and Medicaid Services (CMS), which denies coverage for ESAs above the hemoglobin levels of 10 gm/dL.

US Oncology and its affiliated network of physicians continue to be concerned that the NCD interferences with medically-evidence
'/>"/>

SOURCE US Oncology
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Statement by KCP Chairman Dr. Edward Jones in Response to FDA Advisory Committee on Benefits and Risks of Erythropoietin-Stimulating Agents in Treatment of Kidney Patients
2. Statement From The National Conclave on HIV/AIDS Policy for Black Clergy
3. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
4. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
5. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
6. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
7. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
8. University of Pennsylvania School of Medicine Study Shows Significant Differences in English- and Spanish-speakers Use of Oncology Websites
9. Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label
10. Proteolix Initiates Multicenter Open-label Study of the Safety and Activity of Carfilzomib in Subjects With Relapsed Solid Tumors
11. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... , April 21, 2015  Following is the daily ... LIFESAVING MEDICINE Profile ... important medicines — insulin —became available for general use ... of people suffering from diabetes. Insulin is a hormone ... processing of carbohydrates in the human body. It was ...
(Date:4/20/2015)... April 20, 2015 Research published today in ... Sciences (PNAS) demonstrates that technology invented by ... Casey Eye Institute can improve the clinical ... coherence tomography (OCT) angiography could largely replace current ... OHSU researchers found that OCT angiography ...
(Date:4/20/2015)... ALPHARETTA, Ga. , April 20, 2015  Halyard Health ... discussing financial results and business highlights for the first quarter ... company will issue a news release detailing first quarter results ... conference call will be hosted by Robert Abernathy , ... Chief Financial Officer. To join the live conference ...
Breaking Medicine Technology:U.S. Census Bureau Daily Feature for April 21 2Study shows new technology may improve management of leading causes of blindness 2Study shows new technology may improve management of leading causes of blindness 3Study shows new technology may improve management of leading causes of blindness 4Study shows new technology may improve management of leading causes of blindness 5Halyard Health Inc. To Webcast Conference Call Discussing First Quarter 2015 Financial Results 2
... Pompe Patients May Be Amenable to Chaperone ... ... Amicus Therapeutics, a,biopharmaceutical company developing small-molecule, orally administered,pharmacological chaperones for ... present positive results from an ex,vivo response study and three Phase ...
... Raven,biotechnologies, inc., a privately held company focused on ... for cancer,today announced that it has initiated a ... in combination with gemcitabine in the treatment of,patients ... Pancreatic Cancer Study will be conducted at approximately,20 ...
Cached Medicine Technology:Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study and Phase 1 Studies of AT2220 2Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study and Phase 1 Studies of AT2220 3Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study and Phase 1 Studies of AT2220 4Raven Announces Initiation of a RAV12 Phase 2 Clinical Trial in Metastatic Pancreatic Cancer 2Raven Announces Initiation of a RAV12 Phase 2 Clinical Trial in Metastatic Pancreatic Cancer 3
(Date:4/21/2015)... Bulk food-grade transportation services have ... indicating generally favorable purchasing conditions for buyers. “This market ... and the fact that most bulk food products are ... IBISWorld research analyst Hayden Shipp. “As such, many small ... and regional markets.” Suppliers include Ruan Transportation Management Systems, ...
(Date:4/21/2015)... Antonio, TX (PRWEB) April 21, 2015 ... PRMA is actively involved in various components of ... science fields. , "Breast reconstruction research ... following mastectomy. Despite recent advances, many unanswered ... to provide patients with optimal results," says Dr. ...
(Date:4/21/2015)... The Northeast Football Clinic (NEFC) has trained ... school in Byfield, MA. Applications are being accepted for ... grades 6-12. , The outstanding professional, college, and high ... , Offensive and defensive linemen and linebackers ... most unsung positions on the field, the the success ...
(Date:4/21/2015)... CA (PRWEB) April 21, 2015 ... solutions for biopharmaceutical development, today announced that the ... the University of Ottawa has acquired a Freeslate ... Screening Pressure Reactor (SPR) to accelerate current ... High-Throughput Experimentation Facility where they will be available to ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 This ... pathologists, physical therapist assistants, occupational therapist assistants, teachers, ... and techniques to help children across the autism ... through Education Resources Inc. , ... 2008, this highly acclaimed yoga curriculum addresses learning ...
Breaking Medicine News(10 mins):Health News:Bulk Food-Grade Transportation Services Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Bulk Food-Grade Transportation Services Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 2Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 3Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 4Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 5Health News:US Sports Camps and The Northeast Football Clinic Announce 2015 Lineman/Linebacker Clinic Schedule 2Health News:University of Ottawa Selects Freeslate Reaction Screening System to Support High-Throughput Research at the Centre for Catalysis Research and Innovation 2Health News:University of Ottawa Selects Freeslate Reaction Screening System to Support High-Throughput Research at the Centre for Catalysis Research and Innovation 3Health News:ABC News Interviews Anne Buckley-Reen, Education Resources Inc. Faculty Member, on Yoga Therapy in the Classroom 2
... revealed in unprecedented detail the current global pattern of the ... a number of years. In a study published in ... from the Malaria Atlas Project (MAP), funded mainly by the ... assemble all available data worldwide on the risk of ...
... (HealthDay News) -- Despite the fact that sunburn in childhood ... 25 percent of 14-year-olds in a new U.S. study said ... risky sun exposure increased as kids got older, with older ... of sunscreen than when they were young. In the ...
... classic film "12 Angry Men," Henry Fonda,s character sways a ... succeeded if he had allowed himself to fall sway to ... scientists at the Virginia Tech Carilion Research Institute found that ... and cocktail parties -- can alter the expression of IQ ...
... DNA methylation, a process that shuts down cancer-fighting genes, ... University of Texas MD Anderson Cancer Center report today ... Nature Medicine . The team,s connection of these ... therapies for treating and preventing colorectal cancer. In ...
... with breast cancer experience a decrease in their health-related quality ... a decline in their physical activity, infertility and early onset ... Journal of the National Cancer Institute . ... women, and is the leading cause of death in women ...
... News) -- Younger women with breast cancer may experience a ... mental distress, weight gain and other factors, a new study ... among the other problems these women faced, according to the ... National Cancer Institute . The findings were based on ...
Cached Medicine News:Health News:New malaria maps to guide battle against the disease 2Health News:Only 1 in 4 Young Teens Uses Sunscreen Regularly, Study Finds 2Health News:Group settings can diminish expressions of intelligence, especially among women 2Health News:Group settings can diminish expressions of intelligence, especially among women 3Health News:Inflammatory mediator promotes colorectal cancer by stifling protective genes 2Health News:Inflammatory mediator promotes colorectal cancer by stifling protective genes 3Health News:Younger breast cancer patients have more adverse quality-of-life issues 2Health News:Breast Cancer Before 50 Linked to More Distress 2
... The SG210D combines a slab gel dryer ... convenient gel drying without any hardware setup. The ... fixed in acetic acid, protein/agarose gels, and multiple ... in 60 minutes or less. , Completely ...
Inquire...
... system, Hoefers Easy Breeze can dry as many as ... Mini-Gels (8 x 10 cm) at a time. , ... drying oven, a specially designed loading platform, and two ... no awkward connections., The Gel Frame is largely responsible ...
... HydroTech™ gel drying system, 220-240 V, includes Model ... The Model 583 gel dryer is a vacuum-based ... x 45 cm with variable temperature control and ... a water-based vacuum pump used for pulling vacuum ...
Medicine Products: